BR0314657A - Inibidores de fusão de derivados de peptìdeo de infecção de hiv - Google Patents
Inibidores de fusão de derivados de peptìdeo de infecção de hivInfo
- Publication number
- BR0314657A BR0314657A BR0314657-0A BR0314657A BR0314657A BR 0314657 A BR0314657 A BR 0314657A BR 0314657 A BR0314657 A BR 0314657A BR 0314657 A BR0314657 A BR 0314657A
- Authority
- BR
- Brazil
- Prior art keywords
- peptide derivative
- hiv infection
- fusion inhibitors
- derivative fusion
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 208000031886 HIV Infections Diseases 0.000 title abstract 2
- 208000037357 HIV infectious disease Diseases 0.000 title abstract 2
- 230000004927 fusion Effects 0.000 title abstract 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 241000713311 Simian immunodeficiency virus Species 0.000 abstract 2
- 101800001690 Transmembrane protein gp41 Proteins 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 2
- 230000009385 viral infection Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
- C07K14/162—HIV-1 ; HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, CD4-Binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41279702P | 2002-09-24 | 2002-09-24 | |
| PCT/US2003/029815 WO2004029201A2 (en) | 2002-09-24 | 2003-09-23 | Peptide derivative fusion inhibitors of hiv infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0314657A true BR0314657A (pt) | 2005-08-02 |
Family
ID=32043189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0314657-0A BR0314657A (pt) | 2002-09-24 | 2003-09-23 | Inibidores de fusão de derivados de peptìdeo de infecção de hiv |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US7575750B2 (OSRAM) |
| EP (1) | EP1542718B1 (OSRAM) |
| JP (2) | JP5385497B2 (OSRAM) |
| CN (1) | CN1327897C (OSRAM) |
| AP (1) | AP2203A (OSRAM) |
| AU (2) | AU2003275116A1 (OSRAM) |
| BR (1) | BR0314657A (OSRAM) |
| CA (1) | CA2500248C (OSRAM) |
| CR (1) | CR7806A (OSRAM) |
| EA (1) | EA007918B1 (OSRAM) |
| ES (1) | ES2558680T3 (OSRAM) |
| IL (1) | IL167527A (OSRAM) |
| NZ (1) | NZ539539A (OSRAM) |
| WO (1) | WO2004029201A2 (OSRAM) |
| ZA (1) | ZA200503118B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1479691T3 (da) | 2001-05-31 | 2007-03-12 | John Erickson | Langvarigt aktive fuionspeptidinhibitorer for HIV infektion |
| AU2003275116A1 (en) * | 2002-09-24 | 2004-04-19 | Frontier Biotechnologies Co., Ltd | Peptide derivative fusion inhibitors of hiv infection |
| CN100455594C (zh) * | 2005-12-14 | 2009-01-28 | 中国人民解放军军事医学科学院生物工程研究所 | 抑制hiv病毒融合的多肽及其用途 |
| CN1793170A (zh) * | 2005-12-14 | 2006-06-28 | 中国人民解放军军事医学科学院生物工程研究所 | 抑制hiv病毒融合的多肽及其用途 |
| EP1976876A4 (en) * | 2005-12-22 | 2010-01-13 | Conjuchem Biotechnologies Inc | PROCESS FOR PRODUCING PREFORMED ALBUMIN CONJUGATES AND THERAPEUTIC AGENT |
| WO2008144590A2 (en) * | 2007-05-16 | 2008-11-27 | Conjuchem Biotechnologies Inc. | Long lasting modified antifusogenic peptide for preventing hiv infection |
| WO2012022040A1 (zh) * | 2010-08-19 | 2012-02-23 | 清华大学 | Hiv-1病毒膜融合抑制剂及其应用 |
| CN103664701A (zh) * | 2013-11-29 | 2014-03-26 | 成都普康生物科技有限公司 | [2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸合成路线 |
| JP2022543956A (ja) * | 2019-05-07 | 2022-10-17 | フロンティア バイオテクノロジーズ インク． | 安定なアルブビルチド組成物 |
| CA3183791A1 (en) * | 2020-06-28 | 2022-01-06 | Zvika GRANOT | Neutrophil-binding peptides |
| CN115025218B (zh) * | 2021-07-30 | 2025-03-28 | 前沿生物药业(南京)股份有限公司 | 联用治疗人类免疫缺陷病毒的活性组合及其应用 |
| WO2024238349A1 (en) * | 2023-05-12 | 2024-11-21 | Frontier Medicines Corporation | Identification and characterization of protein sites |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3719667A (en) | 1970-08-24 | 1973-03-06 | Lilly Co Eli | Epimerization of 6-acylamido and 6-imido penicillin sulfoxide esters |
| US3840556A (en) | 1971-05-28 | 1974-10-08 | Lilly Co Eli | Penicillin conversion by halogen electrophiles and anti-bacterials derived thereby |
| US3791667A (en) * | 1972-05-04 | 1974-02-12 | H Haviland | Retractable vehicle passenger cushioning system |
| US5612034A (en) | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
| CA2106314A1 (en) | 1991-04-05 | 1992-10-06 | John P. Burnier | Platelet aggregation inhibitors having high specification for gpiibiiia |
| US5624902A (en) | 1995-06-07 | 1997-04-29 | Torrey Pines Institute For Molecular Studies | Peptide inhibitors of calmodulin |
| US6475491B1 (en) * | 1995-06-07 | 2002-11-05 | Trimeris, Inc. | Treatment of HIV and other viral infections using combinatorial therapy |
| US6268479B1 (en) | 1997-03-12 | 2001-07-31 | The Trustees Of Columbia University In The City Of New York | Intracellular amyloid-beta peptide binding (ERAB) polypeptide |
| US6281331B1 (en) | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
| US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| JP4209086B2 (ja) * | 1999-05-17 | 2009-01-14 | コンジュケム バイオテクノロジーズ インコーポレイテッド | 長期持続性抗新脈管形成ペプチド |
| SI1180121T1 (en) * | 1999-05-17 | 2004-04-30 | Conjuchem, Inc. | Long lasting insulinotropic peptides |
| EP1623994A3 (en) * | 1999-05-17 | 2008-07-16 | ConjuChem Biotechnologies Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| BR0010757A (pt) | 1999-05-17 | 2002-02-19 | Conjuchem Inc | Inibidores de peptìdeo de fusão de longa duração de infecção viral |
| US6750008B1 (en) * | 1999-07-09 | 2004-06-15 | Trimeris, Inc. | Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission |
| CN1172717C (zh) * | 2000-08-18 | 2004-10-27 | 清华大学 | 一种治疗艾滋病的药物及其制备方法 |
| AU2003275116A1 (en) * | 2002-09-24 | 2004-04-19 | Frontier Biotechnologies Co., Ltd | Peptide derivative fusion inhibitors of hiv infection |
-
2003
- 2003-09-23 AU AU2003275116A patent/AU2003275116A1/en not_active Abandoned
- 2003-09-23 EP EP03759385.2A patent/EP1542718B1/en not_active Expired - Lifetime
- 2003-09-23 EA EA200500533A patent/EA007918B1/ru not_active IP Right Cessation
- 2003-09-23 US US10/667,966 patent/US7575750B2/en not_active Expired - Lifetime
- 2003-09-23 AP AP2005003291A patent/AP2203A/xx active
- 2003-09-23 CA CA2500248A patent/CA2500248C/en not_active Expired - Lifetime
- 2003-09-23 BR BR0314657-0A patent/BR0314657A/pt not_active IP Right Cessation
- 2003-09-23 ES ES03759385.2T patent/ES2558680T3/es not_active Expired - Lifetime
- 2003-09-23 NZ NZ539539A patent/NZ539539A/en not_active IP Right Cessation
- 2003-09-23 WO PCT/US2003/029815 patent/WO2004029201A2/en not_active Ceased
- 2003-09-23 CN CNB038164345A patent/CN1327897C/zh not_active Expired - Lifetime
- 2003-09-23 JP JP2004540158A patent/JP5385497B2/ja not_active Expired - Lifetime
-
2005
- 2005-03-17 IL IL167527A patent/IL167527A/en active IP Right Grant
- 2005-04-18 ZA ZA200503118A patent/ZA200503118B/en unknown
- 2005-04-22 CR CR7806A patent/CR7806A/es unknown
-
2009
- 2009-09-25 US US12/567,250 patent/US8470527B2/en not_active Expired - Fee Related
-
2010
- 2010-03-04 AU AU2010200823A patent/AU2010200823B2/en not_active Ceased
- 2010-04-30 JP JP2010105068A patent/JP2010209097A/ja active Pending
-
2013
- 2013-06-25 US US13/926,698 patent/US20140187476A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA200500533A1 (ru) | 2005-12-29 |
| JP2006505536A (ja) | 2006-02-16 |
| US20050089840A1 (en) | 2005-04-28 |
| JP2010209097A (ja) | 2010-09-24 |
| IL167527A (en) | 2013-12-31 |
| EP1542718A2 (en) | 2005-06-22 |
| US20110003735A1 (en) | 2011-01-06 |
| CA2500248A1 (en) | 2004-04-08 |
| US7575750B2 (en) | 2009-08-18 |
| WO2004029201A2 (en) | 2004-04-08 |
| CA2500248C (en) | 2013-03-19 |
| AU2003275116A1 (en) | 2004-04-19 |
| AP2203A (en) | 2011-01-31 |
| AU2010200823A1 (en) | 2010-03-25 |
| AP2005003291A0 (en) | 2005-06-30 |
| EA007918B1 (ru) | 2007-02-27 |
| ZA200503118B (en) | 2006-11-29 |
| EP1542718A4 (en) | 2011-04-06 |
| ES2558680T3 (es) | 2016-02-08 |
| US20140187476A1 (en) | 2014-07-03 |
| WO2004029201A3 (en) | 2004-08-12 |
| AU2010200823B2 (en) | 2011-12-15 |
| JP5385497B2 (ja) | 2014-01-08 |
| US8470527B2 (en) | 2013-06-25 |
| NZ539539A (en) | 2006-11-30 |
| EP1542718B1 (en) | 2015-11-11 |
| CR7806A (es) | 2007-09-07 |
| CN1327897C (zh) | 2007-07-25 |
| CN1668330A (zh) | 2005-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60229677D1 (de) | Langwirkende Fusionspeptidinhibitoren gegen HIV-Infektion | |
| ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
| EA200401437A1 (ru) | Ненуклеозидные ингибиторы обратной транскриптазы для лечения вич инфекции, способ их получения (варианты), способ увеличения периода полупревращения ненуклеозидного соединения, обладающего активностью против ретровирусов, и способ получения фармацевтической композиции, обладающей специфичностью к лейкоцитам | |
| ATE238998T1 (de) | Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore | |
| NO20051969L (no) | Nukleosidderivater for behandling av hepatitt C virusinfeksjon. | |
| TR199903053T2 (xx) | Benzimidazol t�revleri. | |
| NO20020571L (no) | Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse | |
| DK1401826T3 (da) | Pyrazolderivater som inhibitorer for HIV-revers transcriptase | |
| WO2004029201A3 (en) | Peptide derivative fusion inhibitors of hiv infection | |
| FR2792206B1 (fr) | Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1 | |
| DK1476467T3 (da) | IgG3-immunglobulin som beskyttelsesmarkör mod virusinfektionssygdomme og anvendelser deraf | |
| ATE374208T1 (de) | Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung | |
| WO2003061602A3 (en) | Combination therapy for treatment of hiv infection | |
| CA2195125A1 (en) | Difluorostatone antiviral agents | |
| WO2003100036A3 (fr) | Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih. | |
| DK0859613T3 (da) | Anvendelse af flupirtin til forebyggelse og behandling af sygdomme, som er forbundet med beskadigelse af det hæmopoietiske cellesystem | |
| WO2007002172A3 (en) | Hiv-1 protease inhibitors | |
| UA41338C2 (uk) | Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл) | |
| BR0213741A (pt) | composto e composição antiretrovirais | |
| CY1105997T1 (el) | Mακρας διαρκειας αναστολεις πεπτιδιου συντηξης για μολυνση hiv | |
| AP2003002852A0 (en) | Natural antibodies active against HIV virus | |
| WO2008144590A3 (en) | Long lasting modified antifusogenic peptide for preventing hiv infection | |
| MX2024007429A (es) | Terapias de combinacion para infecciones por vih y usos de las mismas. | |
| EP1752469A3 (en) | Long lasting fusion peptide inhibitors for HIV infection | |
| DK0910405T3 (da) | Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07F | Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette] |
Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI |
|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |